Recently diagnosed with HIV? Click here

Tenofovir

Displayed below is content from the NAPWA website tagged with the keyword tenofovir.

Abacavir or tenofovir for first-line?

Positive Living article • Graham Stocks • 24 November 2011

According to the Canadian Observational CohortIn epidemiologyThe branch of medical science that deals with the study of incidence and distribution and control of a disease in a population., a group of individuals with some characteristics in common. A cohort study is a special kind of clinical trialA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. which looks at a treatment or treatment strategy in a cohort of people. collaboration, abacavir (ABC) or tenofovir (TDF) are equally effective in first-line treatment.

The authors found that in their group of treatment-naive patients starting treatment, there was no difference in time to suppression with ABC/3TC (Kivexa) versus TDF/FTC (Truvada). read more »

Tenofovir vs abacavir: the saga continues

Positive Living article • Adrian Ogier • 1 September 2011

Compared to abacavir, tenofovir does increase bone mineral density (BMD) loss but not fracture risk, according to the results from the STEAL trial reported at the IAS Conference in Rome. read more »

Tenofovir may reduce inflammation

Positive Living article • AIDSmeds • 26 May 2011

It appears that the antiretroviralA medication or other substance which is active against retroviruses such as HIV. NRTIA type of anti-HIV drug that works by inhibiting a stage of the HIV life cycle called reverse transcription. Non-nucleosides work in a similar way, but are chemically different. tenofovir (found in Viread, Truvada and Atripla) may also have a calming effect on the immune system and provide protection against infections other than HIV. Laboratory tests have found that tenofovir offered two types of protection. First, it suppressed the production of inflammatory messengers, such as Interleukin-8 (IL-8). read more »

Snippets from ASHM

Positive Living article • Adrian Ogier • 2 December 2010

The Australasian HIV/AIDS Conference was held in Sydney in October. Here are some of the treatment highlights: read more »

AIDS 2010: microbicide breakthrough

Story • Paul Kidd • 21 July 2010

In what is being called a major breakthrough, a trial of a vaginal microbicide gel in South African women has shown for the first time that such a product can be effective against HIV infection. read more »

Antiretrovirals and your kidneys

Positive Living article • www.aidsmap.org • 26 November 2009

Despite having been linked to the kidneys, tenofovir (Viread and also in the combination pill Truvada) appears not to cause more problems than other NRTIA type of anti-HIV drug that works by inhibiting a stage of the HIV life cycle called reverse transcription. Non-nucleosides work in a similar way, but are chemically different. drugs, US investigators have reported. read more »

Bone health and HIV

Positive Living article • Adrian Ogier • 5 June 2009

Those of us with HIV are more likely to have conditions such as osteopenia (low bone mineral density) and osteoporosis (weakened bones) than our negative contemporaries. read more »

FTC approved, ddC to be withdrawn

Positive Living article • Paul Kidd • 19 May 2005

A new antiretroviralA medication or other substance which is active against retroviruses such as HIV. medication, FTC (emtricitabine, Emtriva) was listed on the PBS[Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs.] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. and became available for S100 prescription from 1 April. read more »

Cambodian PREP trial halted

Positive Living article • Paul Kidd • 15 August 2004
HIV prevention

A controversial Cambodian trial of tenofovir for pre-exposure prophylaxis (PREP) is unlikely to proceed after sex workers and the Cambodian government claimed the trial did not include adequate safeguards for the health and human rights of the participants. read more »

Pre-exposure prophylaxis study for Cambodia

Positive Living article • Kirsty Machon • 15 December 2003
HIV prevention

Australian researchers have teamed up with the US and Cambodia to conduct a study of the potential of the HIV antiviralA medication or substance which is active against one or more virusesA small infective organism which is incapable of reproducing outside a host cell.. May include anti-HIV drugs, but these are more accurately termed antiretroviralsA medication or other substance which is active against retroviruses such as HIV.. tenofovir, taken daily, to prevent HIV infection in women at high risk. read more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWA's work and be alerted to new content on the website by following @napwa.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.